Page 2 - Breast Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<p>Patients with breast cancer in conflict zones around the world are being &ldquo;massively under-served&rdquo; by governments, UN aid agencies and other non-governmental organisations, Professor Richard Sullivan told the Advanced Breast Cancer Seventh International Consensus Conference. Among people fleeing conflict zones, either displaced within their own country or across borders to other countries, patients with breast cancer are the &ldquo;single largest group of cancer patients that present to UN agencies and international NGOs,&rdquo; said Prof. Sullivan, who is d...

<p>The majority of people living with advanced breast cancer give up working against their will, according to research presented at the Advanced Breast Cancer Seventh International Consensus Conference. As well as the personal costs of being out of work, the new study shows that there is a significant overall cost to the economy when patients stop working. In Portugal alone, the researchers estimate nearly &euro;29 million is lost in productivity over three years. Similar situations exist in other countries too.</p>

<p>Patients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer if they are treated with a new drug called pyrotinib, according to results from the longest follow-up of the PHOEBE randomised clinical trial in China.&nbsp;Presenting the latest results at the Advanced Breast Cancer Seventh International Consensus Conference (ABC 7), Professor Xichun Hu, of Fudan University Cancer Hospital, Shanghai, China, said the researchers had been able to analyse data on overall survival from the trial up to March 15, 2023.</p>

Research suggests that this chronic disease increases the likelihood of developing an ovarian tumor by up to three times

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.